IB Acquisition Corp.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About IB Acquisition
Services-Commercial Physical & Biological Research, SIC 8731
IB Acquisition Corp. is a blank check company established to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company maintains an opportunistic investment strategy without a restriction to a specific sector, though it focuses on high-growth businesses across fintech, healthcare and life sciences, sports and entertainment, and consumer goods. As an entity with no active operations, it provides prospective acquisition candidates with an alternative path to public markets and growth capital rather than selling direct commercial products or services to typical retail or enterprise end customers.
The company operates from its principal executive offices in Boca Raton, Florida. While organized under the laws of the State of Nevada, it targets potential business combination candidates domiciled across North America, Europe, and Asia, generally seeking prospective partner entities with enterprise values of at least $500 million.
Summary of the business section of IB Acquisition's latest annual report, written by StockData.
Company profile
Company
- Legal name
- IB Acquisition Corp.
- Founded
- 2020
- Headquarters
- Boca Raton, FL
- Address
- 2500 N Military Trail, Suite 160-A 33431
- Phone
- (214) 687-0020
- Employees
- 500, Sep 30, 2025
- Industry
- Services-Commercial Physical & Biological Research
- Incorporated in
- Nevada
- Fiscal year ends
- September 30
- Auditor
- MaloneBailey LLP, Houston, Texas
Stock & identifiers
- Ticker
- IBAC
- Other tickers
- IBACR
- Exchange
- Nasdaq
- IPO date
- Mar 27, 2024
- Shares outstanding
- 5M, Aug 14, 2026
- Public float
- $14.84M, Mar 31, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1998781
- CUSIP
- 44934N108
- ISIN
- US44934N1081
- EIN
- 85-2946784
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
IB Acquisition's leadership is listed in its proxy statement, last filed Sep 4, 2026.
Employees
Headcount reported in annual reports
“● our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; … Our investment strategy is not specific to any sector; however, the management team and board members believe there are compelling investment opportunities in a number of areas including consumer goods, sports and entertainment, and healthcare technology. We anticipate targeting companies domiciled in North America, Europe and Asia, with an ente”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 6, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jul 24, 2026 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| May 13, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Apr 30, 2024 | Delisting | Notice of delisting from exchange (Form 25) |
| Apr 26, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Mar 27, 2024 | IPO | Initial public offering priced (424B4 prospectus) |
| Mar 21, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |